ECM
ORIC icon

ExodusPoint Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

ExodusPoint Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.36M Buy
186,145
+77,310
+71% +$878K 0.02% 725
2025
Q4 		$890K Buy
+108,835
New +$1.25M 0.01% 1036
2025
Q1 		– Sell
-23,417
Closed -$189K – 1853
2024
Q4 		$189K Buy
+23,417
New +$215K ﹤0.01% 1369

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ExodusPoint Capital Management's ORIC Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 71% in Q1 2026, buying an estimated $878K and bringing the position to 186,145 shares worth $2.36M. The position accounts for 0.02% of the portfolio, ranked #725.

ExodusPoint Capital Management first reported a position in ORIC in Q4 2024 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • ExodusPoint Capital Management held 186,145 shares of Oric Pharmaceuticals worth $2.36M as of Q1 2026.
  • ExodusPoint Capital Management bought 77,310 Oric Pharmaceuticals shares in Q1 2026, an estimated $878K.
  • Oric Pharmaceuticals made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #725 holding.
  • ExodusPoint Capital Management first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.